Companies: 10,795·Total market cap: $144.5T
Quantumzyme Corp.

Quantumzyme Corp.

QTZMOTCBasic Materials● Active
$0.80
+$0.20(+33.33%)
Market Cap$31169640
P/E Ratio
52W High$5.04
52W Low$0.0025

Quantumzyme Corp. (QTZM) Revenue

Annual & quarterly revenue history · segment & region breakdown

QTZM · revenue · updated Jun 10, 2026

Core revenue metrics

Quantumzyme Corp. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
1 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Quantumzyme Corp. SEC filings · GAAPUpdated: 2026-06-10

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
QTZM revenue by year · QTZM revenue history · QTZM annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Quantumzyme Corp. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Quantumzyme Corp. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Quantumzyme Corp.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

QTZM revenue · 4 questions

QTZM's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

QTZM revenueQTZM annual revenuewhat is QTZM revenueQTZM TTM revenue

Source: FMP · Quantumzyme Corp. SEC filings · GAAP · Quantumzyme Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026